Summary of serum levels of COMP, resistin, MCP-1, HGF and NGF in validation cohort of patients with PsA (n=73) and OA (n=75)
| Biomarkers | PsA (n=73)* | OA (n=75)* | P value† |
| COMP, ng/mL | 217.3 (182.9–278.3) | 210.3 (166.6–264.7) | 0.3435 |
| Resistin, ng/mL | 36.0 (28.3–51.9) | 24.6 (19.8–34.7) | <0.0001 |
| HGF, ng/mL | 0.6 (0.5–1.0) | 0.2 (0.2–0.3) | <0.0001 |
| MCP-1, pg/mL | 370.0 (269.8–458.4) | 127.6 (106.3–162.7) | <0.0001 |
| NGF, pg/mL | 3.0 (2.0–4.3) | 4.5 (3.3–6.8) | <0.0001 |
*Median (IQR).
†Wilcoxon rank-sum test.
COMP, cartilage oligomeric matrix protein; HGF, hepatocyte growth factor; MCP-1, monocyte chemoattractant protein-1; NGF, nerve growth factor; OA, osteoarthritis.